Farrow Financial’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4K | Hold |
11,500
| – | – | 0.01% | 51 |
|
|
2025
Q1 | $5.19K | Hold |
11,500
| – | – | ﹤0.01% | 50 |
|
|
2024
Q4 | $5.7K | Hold |
11,500
| – | – | ﹤0.01% | 50 |
|
|
2024
Q3 | $10.4K | Hold |
11,500
| – | – | 0.01% | 52 |
|
|
2024
Q2 | $11.5K | Hold |
11,500
| – | – | 0.01% | 50 |
|
|
2024
Q1 | $17K | Sell |
11,500
-5,500
| -32% | -$8.14K | 0.01% | 53 |
|
|
2023
Q4 | $18.5K | Buy |
+17,000
| New | +$18.5K | 0.01% | 51 |
|